Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
71,531,081
Total 13F shares
28,727,743
Share change
-469,296
Total reported value
$155,145,749
Put/Call ratio
19%
Price per share
$5.40
Number of holders
59
Value change
-$5,374,332
Number of buys
35
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 00509G209?
CUSIP 00509G209 identifies ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) as of Q4 2022

As of 31 Dec 2022, Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,727,743 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Deep Track Capital, LP, Sands Capital Ventures, LLC, Knollwood Investment Advisory, LLC, Laurion Capital Management LP, BlackRock Inc., GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and DRIEHAUS CAPITAL MANAGEMENT LLC. This page lists 59 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.